AFFIMED N V's ticker is AFMD and the CUSIP is N01045108. A total of 32 filers reported holding AFFIMED N V in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $19 | -52.5% | 32,036 | +0.5% | 0.00% | -80.0% |
| Q4 2022 | $40 | -99.9% | 31,867 | +18.3% | 0.01% | 0.0% |
| Q3 2022 | $55,000 | -33.7% | 26,939 | -9.7% | 0.01% | -28.6% |
| Q2 2022 | $83,000 | -18.6% | 29,836 | +27.9% | 0.01% | -12.5% |
| Q1 2022 | $102,000 | -46.9% | 23,327 | -29.4% | 0.01% | -61.9% |
| Q4 2020 | $192,000 | +15.7% | 33,023 | -45.5% | 0.02% | +31.2% |
| Q4 2019 | $166,000 | -35.2% | 60,613 | -30.3% | 0.02% | -20.0% |
| Q3 2019 | $256,000 | +84.2% | 87,005 | +80.0% | 0.02% | +150.0% |
| Q2 2019 | $139,000 | +39.0% | 48,327 | -20.4% | 0.01% | +100.0% |
| Q2 2018 | $100,000 | +138.1% | 60,738 | +169.8% | 0.00% | +100.0% |
| Q1 2018 | $42,000 | -62.2% | 22,516 | -73.7% | 0.00% | -66.7% |
| Q4 2017 | $111,000 | +236.4% | 85,562 | +483.0% | 0.01% | +200.0% |
| Q3 2017 | $33,000 | – | 14,676 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Public Equity Management, LLC | 3,209,013 | $6,578,000 | 0.40% |
| Telemetry Investments, L.L.C. | 367,067 | $752,000 | 0.35% |
| NEA Management Company, LLC | 3,888,888 | $7,972,000 | 0.29% |
| DAFNA Capital Management LLC | 92,500 | $190,000 | 0.14% |
| Tekla Capital Management LLC | 1,405,324 | $2,881,000 | 0.11% |
| Perceptive Advisors | 668,214 | $1,369,000 | 0.07% |
| MUHLENKAMP & CO INC | 72,786 | $149,000 | 0.05% |
| Orbimed Advisors | 1,799,700 | $3,689,000 | 0.04% |
| MOORE CAPITAL MANAGEMENT, LP | 250,000 | $513,000 | 0.02% |
| Baker Brothers Advisors | 400,000 | $820,000 | 0.01% |